RIGEL PHARMACEUTICALS INC — Director's Dealing 2009

Apr 1, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2009-03-30

Reporting Person: PAYAN DONALD G (Director, EVP, Pres. Discovery&Research)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-03-30	Stock Option (Right to Buy)	$6.49	A	145000	Acquired	2019-03-30	Common Stock (145000)	Direct

Footnotes

F1: The shares vest monthly over one (1) year from the date of grant.